Aston Pharmacy School, College of Health and Life Sciences, Aston University, Birmingham, UK
Pharmacy Department, United Christian Hospital, Kwun Tong, Kowloon, Hong Kong.
Eur J Hosp Pharm. 2022 Jul;29(4):180-186. doi: 10.1136/ejhpharm-2020-002520. Epub 2021 Jan 20.
This systematic review (SR) was undertaken to identify and summarise any factors which influence the implementation of paediatric clinical pharmacy service (CPS) from service users' perspectives in hospital settings.
Literature search from EMBASE, MEDLINE, Web of Science (Core Collection), Cochrane Library, Scopus and CINAHL databases were performed in order to identify any relevant peer-reviewed quantitative and qualitative studies from inception until October 2019 by following the inclusion criteria. Boolean search operators were used which consisted of service, patient subgroup and attribute domains. Studies were screened independently and included studies were quality assessed using Mixed Methods Appraisal Tool. The study was reported against the 'Enhancing Transparency in Reporting the Synthesis of Qualitative Research' statement.
4199 citations were screened by title and abstract and 6 of 32 full publications screened were included. There were two studies that were graded as 'high' in quality, with four graded as 'moderate'. The analysis has led to the identification of seven factors categorised in five predetermined overarching themes. These were: other healthcare professionals' attitudes and acceptance; availability of clinical pharmacist on ward or outpatient settings; using drug-related knowledge to perform clinical activities; resources for service provision and coverage; involvement in a multidisciplinary team; training in the highly specialised areas and development of communication skills.
Evidence for paediatric CPS was sparse in comparison to a similar SR conducted in the adult population. An extensive knowledge gap within this area of practice has therefore been identified. Nevertheless, majority of the factors identified were viewed as facilitators which enabled a successful implementation of CPS in paediatrics. Further research is needed to identify more factors and exploration of these would be necessary in order to provide a strong foundation for strategic planning for paediatric CPS implementation and development.
本系统评价(SR)旨在从服务使用者的角度确定和总结影响儿科临床药学服务(CPS)实施的任何因素,该研究在医院环境中进行。
通过以下纳入标准,从 EMBASE、MEDLINE、Web of Science(核心合集)、Cochrane 图书馆、Scopus 和 CINAHL 数据库中进行文献检索,以确定任何相关的同行评审的定量和定性研究。使用由服务、患者亚组和属性域组成的布尔搜索运算符。独立筛选研究,并使用混合方法评估工具对纳入的研究进行质量评估。该研究按照“提高定性研究综合报告透明度”的声明进行报告。
通过标题和摘要筛选出 4199 条引文,从 32 篇全文筛选出 6 篇。有两项研究质量评为“高”,四项评为“中”。分析导致确定了七个因素,分为五个预定的总体主题。这些因素是:其他医疗保健专业人员的态度和接受程度;临床药师在病房或门诊环境中的可用性;利用与药物相关的知识开展临床活动;服务提供和覆盖的资源;参与多学科团队;在高度专业化领域的培训和沟通技巧的发展。
与在成人人群中进行的类似 SR 相比,儿科 CPS 的证据很少。因此,在该实践领域发现了广泛的知识差距。尽管如此,确定的大多数因素被视为促进因素,这些因素促进了儿科 CPS 的成功实施。需要进一步研究以确定更多的因素,并对这些因素进行探索,以便为儿科 CPS 实施和发展的战略规划提供坚实的基础。